Skip to main content
PACB
NASDAQ Life Sciences

CFO Exits Days After Q3 Loss as PacBio Turnaround Stumbles

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.6
Mkt Cap
$792.618M
52W Low
$1.07
52W High
$3.435
52W Position info
143% above low
Off High info
24% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

PACB has more than doubled off its 52-week low of $1.07.

Summary

CFO Jim Gibson is stepping down, with Mark Van Oene named interim finance chief. The timing is awkward: it lands the same day PacBio reported a $37.8M Q3 loss on $40.6M revenue with gross margin down to 33%, and roughly three months after the company cut 2026 revenue guidance to $155M-$165M and pushed cash-flow breakeven out. Van Oene is already CEO, so he now holds both roles on an interim basis — thin bench at a company burning cash. Gibson had filed in early October to sell 661,815 shares under a pre-arranged 10b5-1 plan, a sale that settled around $2.06M. A finance chief leaving mid-turnaround, right after a weak quarter, raises questions about the credibility of the narrowed guidance and the restructuring plan. Watch for the 10-Q and any disclosure on the terms of Gibson's departure or a permanent CFO search.

At the time of this announcement, PACB was trading at $2.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $792.6M. The 52-week trading range was $1.07 to $3.44. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

PACB - Latest Insights

PACB
Nov 10, 2026, 4:05 PM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $2.25
Real-time Price: $1.73 info
Change: -$0.519 (-23%) info
Market Cap: $550.751M info
PACB
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.54
Real-time Price: $1.73 info
Change: -$0.810 (-32%) info
Market Cap: $550.751M info
PACB
Nov 04, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.68
Real-time Price: $1.73 info
Change: -$0.950 (-35%) info
Market Cap: $550.751M info
PACB
Nov 04, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.57
Real-time Price: $1.73 info
Change: -$0.840 (-33%) info
Market Cap: $550.751M info
PACB
Aug 06, 2026, 5:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.16
Real-time Price: $1.73 info
Change: +$0.570 (+49%) info
Market Cap: $550.751M info